Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 453

1.

Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter.

He LF, Wang YG, Xiao T, Zhang KJ, Li GC, Gu JF, Chu L, Tang WH, Tan WS, Liu XY.

Cancer Lett. 2009 Dec 28;286(2):196-205. doi: 10.1016/j.canlet.2009.05.024. Epub 2009 Jun 28.

PMID:
19564073
2.

Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.

Wang Y, Huang F, Cai H, Zhong S, Liu X, Tan WS.

J Gene Med. 2008 May;10(5):518-26. doi: 10.1002/jgm.1177.

PMID:
18338833
3.

[The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].

Song Y, Shen K, Yu JR.

Zhonghua Yi Xue Za Zhi. 2007 Nov 6;87(41):2919-24. Chinese.

PMID:
18261307
4.

Enhanced antitumor effect of combining interferon beta with TRAIL mediated by tumor-targeting adeno-associated virus vector on A549 lung cancer xenograft.

Wang Y, He L, He G, Kong Y, Liu X, Cai H, Liu X, Tan W.

Sheng Wu Gong Cheng Xue Bao. 2010 Jun;26(6):780-8.

PMID:
20815258
6.

[Effects of human telomerase reverse transcriptase promoter and survivin promoter in targeted tumor gene therapy].

Zhang Y, Ma H, Liu SL, Liu YX, Zheng DX.

Zhonghua Yi Xue Za Zhi. 2008 Feb 19;88(7):475-9. Chinese.

PMID:
18642790
7.

AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in mice.

Zhang Y, Ma H, Zhang J, Liu S, Liu Y, Zheng D.

Life Sci. 2008 Jun 6;82(23-24):1154-61. doi: 10.1016/j.lfs.2008.03.023. Epub 2008 Apr 10.

PMID:
18485417
8.

Antitumor effect of a novel adeno-associated virus vector targeting to telomerase activity in tumor cells.

Wang YG, Wang JH, Zhang YH, Gu Q, Liu XY.

Acta Biochim Biophys Sin (Shanghai). 2004 Jul;36(7):492-500.

PMID:
15248024
9.

Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.

Komata T, Kondo Y, Kanzawa T, Hirohata S, Koga S, Sumiyoshi H, Srinivasula SM, Barna BP, Germano IM, Takakura M, Inoue M, Alnemri ES, Shay JW, Kyo S, Kondo S.

Cancer Res. 2001 Aug 1;61(15):5796-802.

10.
11.

[Specific antitumor effect of adeno-associated virus vector carrying TRAIL gene under the control of hTERT promoter].

Qi R, Cai Y, Li BH, Lin ZX, Gu JF.

Ai Zheng. 2008 Oct;27(10):1026-33. Chinese.

PMID:
18851780
12.

hTERT/re-caspase-3 system induce apoptosis in hTERT-positive cancer cells.

Yang LF, Zhao Y, Zeng L, Gong JP, Cao Y.

Cancer Biol Ther. 2006 Nov;5(11):1546-53. Epub 2006 Nov 30.

PMID:
17172814
14.

The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.

Wang Y, Huang F, Cai H, Wu Y, He G, Tan WS.

J Cancer Res Clin Oncol. 2010 Dec;136(12):1827-37. doi: 10.1007/s00432-010-0841-8. Epub 2010 Mar 7.

PMID:
20213096
15.

Telomerase-specific replication-selective virotherapy for human cancer.

Kawashima T, Kagawa S, Kobayashi N, Shirakiya Y, Umeoka T, Teraishi F, Taki M, Kyo S, Tanaka N, Fujiwara T.

Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):285-92.

16.

Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity.

Irving J, Wang Z, Powell S, O'Sullivan C, Mok M, Murphy B, Cardoza L, Lebkowski JS, Majumdar AS.

Cancer Gene Ther. 2004 Mar;11(3):174-85.

PMID:
14726958
17.
18.

Tumor-targeted efficiency of shRNA vector harboring chimera hTERT/U6 promoter.

Zhang P, Chen Y, Jiang X, Tu Z, Zou L.

Oncol Rep. 2010 May;23(5):1309-16.

PMID:
20372845
19.

[Study on combined gene therapy for malignant gliomas transfected with antisense hTERT/PTEN in vitro and in vivo].

You YP, Fu Z, Zhao P, Wang CZ, Liu N, Lu AL.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006 Dec;23(6):605-9. Chinese.

PMID:
17160935
20.

[An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter].

Wang YP, Tang XJ, Zhou QH, Che GW, Chen XH, Zhu DX.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Sep;39(5):701-5. Chinese.

PMID:
19024294

Supplemental Content

Support Center